Actual material01Copper Tripeptide-1
A recognizable blue copper peptide for sophisticated formulas centered on visible renewal, vitality and premium peptide positioning.
View ingredientFormulation application guide
Choose a peptide by identity, active basis and formulation role—not by a generic trend label.
Direct answer
Cosmetic peptides are not interchangeable. Copper Tripeptide-1, Acetyl Hexapeptide-8 and Dipeptide Diaminobutyroyl Benzylamide Diacetate have different identities, appearance, processing questions and positioning roles.
Relevant ingredients
Each card leads to grade, appearance, buyer checks and technical questions.
Actual material01A recognizable blue copper peptide for sophisticated formulas centered on visible renewal, vitality and premium peptide positioning.
View ingredient
Actual material02A cosmetic peptide for targeted products designed around the appearance of expression lines and smoother-looking skin.
View ingredient
Actual material03A specialty cosmetic peptide for high-value skincare concepts focused on refined texture and a smooth, rested appearance.
View ingredientA category name such as copper peptide or expression peptide is not enough. Align INCI, sequence or complex identity, assay method and active basis.
Supplier solutions may contain a low concentration of peptide in a carrier. Do not compare inclusion rates until both products are converted to the same active basis.
Review pH, temperature, chelators, reducing agents, preservatives, color and packaging before committing to a multi-peptide system.
Evaluation workflow
Application FAQ
No. Commercial forms, active concentrations and grade recommendations differ. Use the selected grade's TDS and calculate on the correct active basis.
No unless the material is genuinely supplied under that trademark with authorization and its supporting dossier. Tender products are identified by INCI and agreed specification.
No. They are presented solely as cosmetic raw materials for professional topical formulation, not for injection, ingestion or therapeutic use.
Discuss the brief